C4 Therapeutics, Inc. · NASDAQ:CCCC
BlackRock, Inc. reported a 6.90% stake in C4 Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 27, 2026
BlackRock, Inc. reported a 6.90% stake in C4 Therapeutics, Inc., 7,678,906 shares, as a passive investor on Jun 30, 2026. Filed Jul 27, 2026 (Schedule 13G).
- Stake
- 6.90%
- Shares
- 7,678,906
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 6.90% | 7,678,906 |
Source
Related
- C4 Therapeutics, Inc.
- BlackRock, Inc.
- C4 Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 16, 2025
- Form 4 · Anderson Kenneth Carl · Oct 2, 2026
- Form 4 · Grogan Donna Roy · Oct 2, 2026
- Form 4 · Adams Kendra · Sep 21, 2026
- Schedule 13G/A · Lynx1 Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026